Dallas- OTCPicks.com’s Daily OTC Stocks Newsletter presents a range of the hottest small cap, micro cap and penny stocks trading on the OTC and OTCBB markets. In addition to our Newsletters, OTCPicks.com is quickly becoming the premier community destination for small cap and micro cap traders to meet up and discuss their top stock picks.
Visit http://www.otcpicks.com/hotpicks.htm today to sign up for our Free Daily Email Newsletter and News Alerts.
Sign up for our Free Red Hot Stock Picks List at
http://www.otcpicks.com/hotpicks.htmJoin us on Twitter at
www.twitter.com/otcpicksJoin us on Facebook at
www.facebook.com/otcpicksSOMAXON PHARMACEUTICALS INCORPORATED (NASDAQ: SOMX)
"Up 98.48% in after-hours trading on Thursday"
Headquartered in San Diego, CA, Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology. A New Drug Application (NDA) for Silenor® (doxepin), Somaxon’s drug candidate for insomnia, has been filed with the U.S. Food and Drug Administration and currently is under review.
SAEHAN BANCORP INCORPORATED (OTCBB: SAEB)
"Up 56.57% on Thursday"
Saehan Bancorp is a bank holding company with headquarters in Los Angeles, California. Its wholly owned subsidiary, Saehan Bank, offers a comprehensive range of financial solutions to meet the needs of the Korean-American community in Los Angeles. Saehan Bancorp is committed to satisfying customers and creating shareholder value. Its ten retail branch offices, International Department, and SBA Department of Saehan Bank focus on fulfilling these commitments to customers and shareholders.
QUEST MINERALS & MINING CORPORATION (OTC: QMIN)
"Up 78.57% on Thursday"
Quest Minerals & Mining Corp., or Quest, acquires and operates energy and mineral related properties in the southeastern part of the United States. Quest focuses its efforts on properties that produce quality compliance blend coal.
CHROMOCURE INCORPORATED (OTC: KKUR)
"Up 33.33% on Thursday"
ChromoCure develops and provides proprietary cancer detection systems. The Company owns its technology and provides its systems on a revenue sharing basis. The Company's proprietary ChromoCure CS200 Chromosomal Scanner system measure the unique genomic characteristic found in 100% of all cancers and never found in normal cells. The Company believes its technology has an effective accuracy of 100% for all cancers at all stages. The Company believes its technology superior and will become the gold standard for cancer detection worldwide. The Company's technology and cancer expertise also suggest non-toxic and non-invasive approaches to cancer therapy and cure research. The Company will release progress reports on these initiatives from time to time.
About OTCPicks.com
OTCPicks.com is an Internet destination for investors seeking information on smallcap and microcap and penny stocks. The web site features growing micro cap and penny stock companies. We publish a daily Free email newsletter highlighting the most active Pinksheets, OTCBB and penny stocks. To feature a company on our web site please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.
Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.
Disclosure: OTCPicks.com has not been compensated by any of the companies covered in this release.
OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.
